Long-term benefit of intravenous immunoglobulins in cadaveric kidney retransplantation

Transplantation
M N PeraldiJ D Sraer

Abstract

Renal retransplantation can be hampered by the presence of anti-HLA alloantibodies. Previous studies have documented in vitro and in vivo suppression of these antibodies by intravenous immunoglobulins (IVIg). We conducted a randomized study in 41 patients, who have received a second cadaveric transplant between 1989 and 1994. They all were treated with a quadruple-immunosuppressive protocol. In addition, 21 patients received 0.4 g/kg/day of IVIg, on the first 5 days after transplantation. The two groups of patients were identical for age, sex, duration of the first graft, duration of cold ischemia, anti-HLA sensitization, HLA matching, the number of acute rejection episodes, and the incidence of cytomegalovirus infection. The 5-year survival rate was significantly higher in the group of patients treated with IVIg: 68% versus 50% in the control group. The only significant factor associated with IVIg infusion and better survival was a shorter delay of graft function (3.4 +/- 1.0 days versus 9.9 +/- 1.6 days). In conclusion, this randomized study demonstrates that IVIg treatment is associated with better long-term graft survival in retransplanted patients. This beneficial effect may be related to a long-lasting immunosuppressive e...Continue Reading

References

Jan 1, 1979·Transplantation·N L AscherJ S Najarian
Jan 1, 1991·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C Garcia CantonJ A Traver
Jan 1, 1991·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·E RondeauJ D Sraer
Jun 4, 1987·The New England Journal of Medicine·E ReedN Suciu-Foca
Jan 1, 1994·Clinical Transplants·M Hirata, P I Terasaki
Aug 11, 1994·The New England Journal of Medicine·M Suthanthiran, T B Strom
Jan 27, 1995·Transplantation·T G PetersJ W Blanton
Mar 9, 1995·The New England Journal of Medicine·M Brezis, S Rosen

❮ Previous
Next ❯

Citations

Mar 27, 2001·Transplantation Proceedings·P P LukeR Shapiro
Feb 9, 2005·Transplantation·Renaud SnanoudjBernard Charpentier
Jul 26, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Jacqueline M Garonzik WangDorry L Segev
Aug 6, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Annaë Liu, Mélisande Bernard
Jan 17, 2002·The Urologic Clinics of North America·P P Luke, M L Jordan
Nov 30, 2005·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Peter BorosJonathan S Bromberg
Jan 12, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S C JordanA A Vo
Jun 7, 2003·Cardiology Clinics·Silviu ItescuKatherine Lietz
Oct 28, 2016·Transplant International : Official Journal of the European Society for Organ Transplantation·Yosu LuqueChristophe Legendre
Sep 26, 2003·Transfusion·Irina Knezevic-Maramica, Margot S Kruskall
Nov 18, 2003·Immunological Reviews·Attapong VongwiwatanaPhilip F Halloran
Mar 4, 2017·Journal of Immunology Research·Nils LachmannJohannes Waiser
Aug 31, 1999·The Annals of Pharmacotherapy·J A HaskinD U Blank
Aug 10, 2000·Progress in Cardiovascular Diseases·S ItescuM D Schuster

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.